Abstract
Congenital lactic acidosis due to pyruvate dehydrogenase phosphatase (PDP) deficiency is very rare. PDP regulates pyruvate dehydrogenase complex (PDC) and defective PDP leads to PDC deficiency. We report a case with functional PDC deficiency with low activated (+dichloroacetate) and inactivated (+fluoride) PDC activities in lymphocytes and fibroblasts, normal activity of other mitochondrial enzymes in fibroblasts, and novel biallelic frameshift mutation in the PDP1 gene, c.575dupT (p.L192FfsX5), with absent PDP1 product in fibroblasts. Unexpectedly, the patient also had low branched-chain 2-ketoacid dehydrogenase (BCKDH) activity in fibroblasts with slight elevation of branched-chain amino acids in plasma and ketoacids in urine but with no pathogenic mutations in the enzymes of BCKDH, which could suggest shared regulatory function of PDC and BCKDH in fibroblasts, potentially in other tissues or cell types as well, but this remains to be determined. The clinical presentation of this patient overlaps that of other patients with primary-specific PDC deficiency, with neonatal/infantile and childhood lactic acidosis, normal lactate to pyruvate ratio, elevated plasma alanine, delayed psychomotor development, epileptic encephalopathy, feeding difficulties, and hypotonia. This patient exhibited marked improvement of overall development following initiation of ketogenic diet at 31 months of age. To the best of our knowledge, this is the fourth case of functional PDC deficiency with a defined mutation in PDP1. Synopsis: Pyruvate dehydrogenase phosphatase (PDP) regulates pyruvate dehydrogenase complex (PDC) and defective PDP due to PDP1 mutations leads to PDC deficiency and congenital lactic acidosis.
| Original language | English |
|---|---|
| Pages (from-to) | 26-35 |
| Number of pages | 10 |
| Journal | JIMD Reports |
| Volume | 48 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 8 2019 |
Bibliographical note
Publisher Copyright:© 2019 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.
Funding
National Institutes of Health, Grant/Award Number: RDCRN 5U54NS078059-05 project NAMDC 7413 grant; Clinical and Translational Science Collaborative (CTSC) CWRU Core Utilization Pilot Grant 2014, Grant/Award Number: 05496 We thank Ms. Sarah Aufmuth for her assistance with the informed consent process for this study. We thank Dr. Britt Johnson at Invitae for facilitating the sequencing and del/dup analyses of the BCKDHA, BCKDHB, DBT, and PPM1K genes. This research was supported in part by funds from the Clinical and Translational Science Collaborative (CTSC) CWRU Core Utilization Pilot Grant 2014 (05496) (to J.K.B.) and NIH RDCRN 5U54NS078059-05 project NAMDC 7413 grant (to J.K.B. and S.D.D.).
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | 05496, RDCRN 5U54NS078059-05 |
| Department of Biotechnology, Ministry of Science and Technology, India |
Keywords
- PDP1
- branched-chain 2-ketoacid dehydrogenase
- developmental delay
- lactic acidosis
- pyruvate dehydrogenase complex deficiency
- pyruvate dehydrogenase phosphatase deficiency
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Biochemistry, Genetics and Molecular Biology (miscellaneous)